Clinical trials indicate that Wegovy users can achieve up to 15% body weight loss over 68 weeks
Oral vs Injections: Currently, Semaglutide oral formulation is showing an impressive 15.9% reduction in weight at week 60 slightly lower than the injectables which is 17.9% at week 60
Options might include trying a different GLP-1 medication to see if you respond better, staying at a lower dose where side effects are more manageable, taking periodic breaks from treatment (though this causes weight regain), or considering alternative weight loss approaches
Seek urgent medical attention for severe persistent vomiting, signs of dehydration, severe abdominal pain (especially if radiating to the back), or vomiting blood
Only one of the trials included in the systematic review used the next-generation GLP-1 agonist semaglutide to treat obesity in adolescents aged 1218 years, and none used the combined GLP-1 and glucose-dependent insulinotropic peptide agonist, tirzepatide
Light activity after meals, like walking, can also support gut motility. He also said to limit foods which could exacerbate the symptoms, noting: Its worth cutting back on foods known to produce excess gas, such as beans, fizzy drinks, and artificial sweeteners
